Ambrosia Biosciences Inc., named after the drink of the Greek gods, secured a $100 million series B to advance its preclinical pipeline of oral obesity drugs. The startup formed after Pfizer Inc.
Renovare Therapeutics, Inc., a privately-held biotechnology company pioneering regenerative therapeutics for osteoarthritis, today announced its formal launch from stealth mode and collaboration with ...
Presented at ASCO Annual Meeting, virtual, May 29-31, 2020; World Congress on Lung Cancer, virtual, January 28-31, 2021; ASCO Annual Meeting, virtual, June 4-8, 2021 ...
Old Dog, New Tricks: Oxybutynin for the Treatment of Androgen Deprivation Therapy–Related Vasomotor Symptoms Presented at ASCO Annual Meeting, virtual, May 29-31, 2020; World Congress on Lung Cancer, ...
NetworkNewsAudio announces the Audio Press Release (APR) titled “When Science Becomes an Asset: How Advancing Drug Pipelines Are Driving Real-Time Valuation in Biotech,” featuring Oncotelic ...
The startup is developing “modified DNA” therapies it claims can combine the strengths of multiple approaches, from messenger RNA to gene therapy.
Zacks Investment Research on MSN
Three best genomics stocks for your portfolio in 2026
An updated edition of the Feb. 20, 2026, article. Genomics involves a thorough study of genomes (an organism’s complete set ...
BOSTON, April 08, 2026 (GLOBE NEWSWIRE)-- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage memory T ...
Christopher Lewis, Umoja Biopharma, explores how AI can streamline compliance, cut investigation time, and free skilled workers for higher-value tasks Disclaimer: The views and opinions expressed in ...
This year, my company celebrates its 50th anniversary as a partner to scientists and innovators. The company was started in 1976, and strategic acquisitions and changes over the past decade, including ...
France-based investment group Jeito Capital has closed its second fund, raking in €1 billion ($1.2 billion), which it claims is the largest ever raise for an independent European fund dedicated to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results